[ad_1]
Despite the presence of the vaccine, Morocco has the highest incidence of cervical cancer in the Middle East and North Africa, with 2,665 deaths in 2018. It ranks third among the causes of death by cancer among Moroccan women.
Reading time: 3 & # 39;
DR
The cervical cancer mortality rate, caused by the human papillomavirus (HPV), has doubled despite the presence of the vaccine, with cervical cancer now ranking second in terms of cancer deaths among women in Canada. Morocco in the last six years.
The number of cases of the disease has increased from 2258 new cases per year in 2012 to 3388 new cases in 2018. As for the number of deaths, it has increased from 1076 in 2012 to 2465 in 2018, Morocco records the cancer rate of The highest cervix in the Middle East and North Africa, according to a statement issued by the Regional Alliance for the Elimination of HPV and the Regional Office of the Global Alliance for Treatment Preparedness.
"The tragedy is that we know how to prevent, detect and treat HPV-related diseases," said Halim Qaddari, director of the Global Coalition for Drug Preparedness in the Middle East and North Africa. Must be overcome to eliminate these cancers and save lives. "
The vaccine itself protects against the vast majority of cervical cancers and other cancers caused by the virus, such as anus, penis and certain types of pharynx and bad warts.
Since 2006, a vaccine approved and made available to prevent transmission of the virus before the start of bad life, with a 100% effectiveness in preventing HPV infection, is now available as part of the national program. vaccination of more than 90 countries. Worldwide and in regions such as Libya, Senegal and the United Arab Emirates.
"The time has come to vaccinate our children against the human papilloma virus," said Aisha Kharbash, female doctor and head of the Ibn Sina University Hospital Department in Rabat, and vice president of the Association. Moroccan for the control of bad infectious diseases. "Today's vaccine will save lives tomorrow," he said. The total cost of health care for cervical cancer in Morocco was estimated at $ 1,589 one year after diagnosis, while the wholesale price of HPV vaccine was set at $ 9.58 per dose in countries whose income and area are similar to that of Morocco.
The statement calls on the Moroccan authorities to prioritize the inclusion of HPV vaccine in the vaccination schedule for boys and girls aged 9 to 13 and make it accessible to all at-risk populations under 45 years of age. .
The communication also requested that this inclusion be accompanied by a comprehensive program to address high rates of HPV and cervical cancer, as well as an early three-year screening of the group 25 to 65 – where coverage rates are only 10% in Morocco. , Equitable access to treatment and badgesic care, as well as extensive health education and awareness campaigns.
[ad_2]
Source link
